Thilo Buck



Thilo completed a bachelor’s degree (magna cum laude; 2012) in psychology with minors in chemistry & biology in the USA (UNO), a research master’s (2014) in Neuroscience & Neuropharmacology at the University Bordeaux & Free University Amsterdam (Erasmus Mundus NEURASMUS scholar), and his doctoral research (2022) on viral vector-based gene therapy on the eye on animal and human iPSCs differentiated to retinal organoids at the Leiden University Medical Center (LUMC). Experiencing the roadblocks in bench-to-bedside personalized medicines for ATMPs, after his doctoral work he focused on viral vector process development & technical writing in pharmaceutical manufacturing at NecstGen (2021). There he primarily worked on analytical development, USP (suspension cells), DSP (Äkta systems), and agile project management. Between 2012-2015 he worked as a part-time clean room engineer on (re-)qualification (DQ, IQ, OQ, PQ, airflow & particle measurements) and installation (e.g., filters, walls) at various manufacturing facilities while working for the company bc-technology. He is a member of ISPE and DARQA and wants to actively contribute to the development of bench-to-bedside personalized medicines.


Thilo (1988) loves outdoor sports (such as hiking, climbing, bouldering and kiting), different cultures (e.g., teaching in Cambodia), and spending time with his family & friends (especially in Germany, the Netherlands, and the USA).


  • ATMPs (viral vectors & stem cell differentiation)
  • Analytical & process development
  • Writing (papers, grants, technical) & presentations (congresses)
  • Agile projectmanagement (SCRUM)
  • Quality by design / Design-of-Experiment
  • C&Q / validation
  • Mentoring